Chevallard Daniel R. bought LENZ

November 7, 2025 · Form 4 insider transaction

Chevallard Daniel R. bought 20 shares of LENZ Therapeutics, Inc. at $22.71 per share, a transaction worth $454.20. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.